VKTX
Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Monday, January 5, 2026 BiopharmaWatch Research 1 min read Key Takeaway: Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Price reaction · baseline $35.42 (2026-01-02 close) · 2 other VKTX headline(s) in the window, move may be shared
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss
Full Press Release Details
Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference.